Bringing together exceptional physicians and scientists to investigate and improve the prevention, detection and treatment of cancer in North Carolina and across the globe| UNC Lineberger
Siddharth Sheth, DO, MPH, is a UNC Lineberger Comprehensive Cancer Center member specializing in clinical trials and translational research in head and neck cancer, and immunotherapy.| UNC Lineberger
Jeffrey Blumberg is a UNC Lineberger member and a head and neck surgical oncologist involved in clinical research.| UNC Lineberger
Get Real & Heel is a unique exercise program designed to serve all cancer patients and survivors in North Carolina.| Get Real & Heel
Robert Ferris, MD, PhD, and colleagues report that a single administration of autologous tumor-infiltrating lymphocyte cell therapy helped stabilize metastatic head and neck squamous cell carcinoma in some patients. The post Immune cell therapy for advanced head and neck cancer helps stabilize disease appeared first on UNC Lineberger.| UNC Lineberger
Dale Ramsden, PhD, was presented with the Battle Award for his research on how cells repair DNA double-strand breaks, a critical process for maintaining genome stability and preventing cancer-causing mutations. The post Ramsden receives Battle Award for groundbreaking genome stability research appeared first on UNC Lineberger.| UNC Lineberger
UNC Lineberger has launched a first-of-its-kind clinical trial aimed at improving outcomes in BRAF wildtype anaplastic thyroid cancer (ATC). Siddharth Sheth, DO, MPH, and Jeffrey Blumberg, MD, FACS, are leading the trial.| UNC Lineberger
We are interested in understanding the mechanisms that cancers have evolved to suppress the generation of tumor antigen-specific immune responses and how this knowledge can be exploited for the development of novel and more effective cancer immunotherapy strategies.| Hanks Lab
Brent Hanks, MD, PhD, is a UNC Lineberger Comprehensive Cancer Center member and a laboratory-based physician-scientist that manages advanced skin cancer patients as well as patients with upper gastrointestinal malignancies.| UNC Lineberger
We are a cancer research and treatment center at the University of North Carolina at Chapel Hill serving patients at the N.C. Cancer Hospital.| UNC Lineberger
Bringing together exceptional physicians and scientists to investigate and improve the prevention, detection and treatment of cancer in North Carolina and across the globe| UNC Lineberger
Nine UNC Lineberger members wrote some of the most influential scientific papers in the past decade, according to Clarivate.| UNC Lineberger
Gianpietro Dotti, MD, and colleagues report in Nature Immunology they have identified a cocktail of three different drugs that can be used to generate more robust CAR-Ts to fight cancer.| UNC Lineberger
Bringing together exceptional physicians and scientists to investigate and improve the prevention, detection and treatment of cancer in North Carolina and across the globe| UNC Lineberger
The Foundation for the Accreditation of Cellular Therapy awarded accreditation without any deficiency citations to UNC Lineberger’s Advanced Cellular Therapeutics Facility.| UNC Lineberger
UNC Lineberger's Barbara Savoldo and Stephanie Wheeler were recently approved as named distinguished professors.| UNC Lineberger
Members Gallery| UNC Lineberger
Driving Directions Physical Address: 410A Country Club Drive Chapel Hill, NC 27514 A few tips: You’ll be going through a residential neighborhood. Go past Laurel Hill Road. Follow the road until it opens up to a large parking area overlooking tennis courts. The facility is down and to the right. Parking Information Please park in … Read more| Get Real & Heel
We’ll develop an individualized exercise plan that will help you manage your cancer treatment related symptoms.| Get Real & Heel
Trevor Hackman is a head and neck surgical oncologist at the UNC Lineberger Comprehensive Cancer Center in Chapel Hill, NC.| UNC Lineberger
Join us in September for an exciting day-and-a-half meeting featuring 16 presentations on the latest cancer research findings, as well as celebrating UNC Lineberger's 50 years of discovery. The post 48th Annual UNC Lineberger Scientific Symposium appeared first on UNC Lineberger.| UNC Lineberger
Chad Pecot, MD, and colleagues have developed a “two-in-one” molecule that targets hard-to-treat cancers by silencing two key genes — KRAS and MYC — while also delivering drugs directly to affected tumors. The post New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes appeared first on UNC Lineberger.| UNC Lineberger
Kwame Kwofie, a citizen of Ghana, found himself in uncharted territory when he faced a head and neck cancer diagnosis thousands of miles away from home.| UNC Lineberger
UNC Lineberger's J. Kaitlin Morrison, PhD, and Carrie Lee, MD, PhD, launched a study to investigate whether UNC Health can successfully conduct hybrid cancer clinical trials across the state.| UNC Lineberger
Naim Rashid, PhD, engages in collaborative studies at UNC Lineberger, working on problems relating to genomics and clinical studies.| UNC Lineberger
Chuck Perou researches identifying the drivers of metastatic disease and the role of the adaptive immune system in breast tumor progression.| UNC Lineberger
UNC Lineberger will lead the development of a next-generation clinical trial for metastatic breast cancer. The new trial design will adapt treatment plans in near real-time by analyzing changes in each patient’s cancer and matching it to the most promising therapy.| UNC Lineberger
Lisa Carey, MD, ScM, FASCO, was honored by OncLive as one of its 2025 Giants of Cancer Care for her significant contributions advancing the treatment and study of breast cancer.| UNC Lineberger
UNC Lineberger celebrated emerging scientists and clinicians at its annual training awards ceremony, recognizing outstanding graduate students and postdoctoral fellows poised to advance cancer research and patient care.| UNC Lineberger
Joshua Zeidner, MD, is a UNC Lineberger Comprehensive Cancer Center member who leads the Leukemia Clinical Trials Research Protocol Office Disease Group.| UNC Lineberger
Joshua Zeidner, MD, and colleagues report that a combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid leukemia showed high rates of complete remission in an early-phase clinical trial.| UNC Lineberger
Lisa Carey, MD, ScM, FASCO, is the Deputy Director of Clinical Sciences at UNC Lineberger. Her clinical interest is in breast cancer.| UNC Lineberger
Hanks has joined the UNC Lineberger Comprehensive Cancer Center, the UNC School of Medicine and UNC Health as an associate professor of medicine.| UNC Lineberger
Gianpietro Dotti, MD, is a UNC Lineberger Comprehensive Cancer Center member and researcher with particular interest in developing CAR-T for the treatment of solid tumors.| UNC Lineberger
Barbara Savoldo, MD, PhD, is a UNC Lineberger member and the assistant director of the UNC Lineberger Immunotherapy Program.| UNC Lineberger
UNC Lineberger has been selected for the newly launched Cancer Screening Research Network, which will evaluate promising and emerging cancer screening technologies.| UNC Lineberger
Robert Ferris, MD, PhD, has been named the executive director of UNC Lineberger Comprehensive Cancer Center effective October 1.| UNC Lineberger